Advanced Medical Solutions Grp PLC
13 October 2005
Lapse and issue of Executive Share Options
Winsford UK: Advanced Medical Solutions, ('AMS' or the 'Company'), the global
woundcare technology company, announces that 750,000 and 375,000 share options
held by Don Evans, Chief Executive Officer, and Mary Tavener, Finance Director,
respectively, have lapsed as a result of the Company's Share Options Scheme
performance conditions.
Following the lapse of these share options, which represent 54.9 per cent. and
55.6 per cent. of Don Evans' and Mary Tavener's total holding in share options
in the Company, the Board granted 1,865,173 new share options to Don Evans and
1,348,571 new share options to Mary Tavener under the Advanced Medical Solutions
Long Term Incentive Plan on 12 October 2005. As a consequence, Don Evans and
Mary Tavener now have an interest in 2,481,839 options and 1,648,571 options,
respectively, representing 1.75 per cent. and 1.16 per cent. of the Company's
issued share capital.
These new options will be priced at the average market price of 8.75p and are
subject to performance conditions over a three year period to vest.
For further information, please contact:
Advanced Medical Solutions Group plc Tel : +44 (0) 1606 545508
Don Evans, Chief Executive
Mary Tavener, Finance Director
www.admedsol.com
Buchanan Communications Tel: +44 (0) 20 7466 5000
Mark Court, Mary-Jane Johnson
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.